Effect of Docosahexaenoic Acid Supplementation on neonatal outcomes of pereterm infants

Phase 3

Recruiting

• Conditions: utrition of premature babies / Growth of premature babies / Prognosis of premature babies.

• Registration Number: IRCT20221120056556N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 384

Inclusion Criteria

Preterm infants with gestational age less than 34 weeks.
Birth weight less than 2000 gr.

Exclusion Criteria

Infants need to major surgery
Infants with major congenital anomalies
Exclusively formula fed infants
Discharge to home on less than 14th day of life
Infants of mother whit special treatment diet

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determining the effect of Docosahexaenoic acid on the growth indices of premature infants. Timepoint: During the study, the growth indices will be checked daily to measure weight and weekly to measure height and head circumference, and they will be checked until the time the baby is admitted to the hospital. Method of measurement: A scale will be used to measure weight and a meter will be used to measure height.

Secondary Outcome Measures

Name	Time	Method
Investigating the effect of Docosahexaenoic acid on the incidence of intraventricular hemorrhage in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: With brain ultrasonography.;Investigating the effect of Docosahexaenoic acid acid acids on the incidence of neonatal sepsis in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: Clinical finding and blood culture examination.;Investigating the effect of Docosahexaenoic acids on the incidence of neonatal necrotizing enteroculitis in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: clinical and radiological findings.;Investigating the effect of Docosahexaenoic acids on the incidence of retinopathy of prematurity in preterm infants. Timepoint: During the whole time of the baby's stay in the hospital. Method of measurement: Based on the retinal exam by ophthalmologist.